TERESA DRESCHER: Open Payments
NPI 1417540881 · MIDDLETOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 91 payments from 14 companies in 2025. Trend: 2023 $123 · 2024 $463 · 2025 $1,603
Food & beverage: $1,603
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $374 |
| ABBVIE INC. | 22 | $311 |
| Axsome Therapeutics, Inc. | 5 | $171 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| PFIZER INC. | 9 | $145 |
| Lilly USA, LLC | 4 | $73 |
| Amgen Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Insulet Corporation | 2 | $53 |
Products named: Ozempic, Auvelity, VRAYLAR, AIRSUPRA, Wegovy, QULIPTA, MOUNJARO, EVENITY.
Industry payments across IN — which companies pay providers there.
